Application 020470
- Type
- NDA
- Sponsor
- BAYER HEALTHCARE LLC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 002 | CLARITIN-D 24 HOUR | LORATADINE; PSEUDOEPHEDRINE SULFATE | TABLET, EXTENDED RELEASE;ORAL | 10MG;240MG | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 11523-4332 | Claritin-D | Loratadine and pseudoephedrine sulfate | Bayer HealthCare LLC. | NDA | Current |
| 11523-4332 | Claritin-D | Loratadine and pseudoephedrine sulfate | Bayer HealthCare LLC. | NDA | Current |
| 11523-4332 | Claritin-D | Loratadine and pseudoephedrine sulfate | Bayer HealthCare LLC. | NDA | Current |
| 11523-4332 | Claritin-D | Loratadine and pseudoephedrine sulfate | Bayer HealthCare LLC. | NDA | Current |
| 11523-4332 | Claritin-D | Loratadine and pseudoephedrine sulfate | Bayer HealthCare LLC. | NDA | Current |
| 70518-2761 | Claritin-D | Loratadine and pseudoephedrine sulfate | REMEDYREPACK INC. | NDA | Current |
| 70518-2761 | Claritin-D | Loratadine and pseudoephedrine sulfate | REMEDYREPACK INC. | NDA | Current |
| 70518-2761 | Claritin-D | Loratadine and pseudoephedrine sulfate | REMEDYREPACK INC. | NDA | Current |